中國旭陽集團(01907.HK)中期收益增加21.1%至225.3億元 中期息12.3分
格隆匯8月26日丨中國旭陽集團(01907.HK)發佈公吿,截至2022年6月30日止六個月,收益約為人民幣225.301億元,較2021年同期增加約21.1%;公司股東應占溢利約為人民幣17.37億元,較2021年同期增加約0.8%;每股基本盈利為人民幣39.14分,擬派中期股息每股人民幣12.30分(相當於每股14.09港仙)。
公吿表示,在2022年,集團將保持增長及擴張步伐,以應對未來不同的挑戰及為公司股東創造更多價值。於過往年度,集團通過提供運營管理服務,以及透過聚焦中國和海外的機遇,組建和收購實體的方式實現增長及擴張。此外,集團在多個產品(主要是焦炭和己內酰胺)擴張產能。集團矢志取得己內酰胺的全球領先地位。到2022年中,呼和浩特生產園區及印尼蘇拉威西省的青山工業園區的擴張計劃如期進行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.